• BX Home
  • Abbott Laboratories: News [Page 23]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

ABBOTT LABORATORIES

Abbott Laboratories is a diversified pharmaceuticals healthcare company headquartered in Abbot Part, Illinois. It operates in four segments: pharmaceutical products; diagnostic products; nutritional products; and vascular products. In 1985, Abbott develop dthe first HIV screen test. The company’s drug portfolio includes Humira, Synthroid, and Dupakote; and its most popular nutritional product is Ensure.

Abbott Laboratories is part of Business Exchange, suggested by Maki Yamasaki. This topic contains 921 news and 191 blog items. Read updated news, blogs, and resources about Abbott Laboratories. Find user-submitted articles and reactions on Abbott Laboratories from like-minded professionals.

News

Please add new articles to this topic

India gains bigger role in drug productionmore

similar predictions. Big Pharma has come calling, too. Earlier this year Piramal sold his generic drug business to...

India Expands Its Global Role in Drug Productionmore

Big pharmaceutical companies have come calling, too. Earlier this year Mr. Piramal sold his generic drug business to...

Abbott Labs CEO Miles White bets big on emerging marketsmore

Buffeted by questions about new sources of sales growth at Abbott Laboratories, CEO Miles White is searching for...

UPDATE: SkyePharma Falls On Latest Flutiform Blowmore

effects at different doses. The drug was first submitted for FDA approval in 2007 but SkyePharma and partner Abbott...

Abbott enters final clinical trial of MS drugmore

Abbott Laboratories and its Massachusetts biotech partner have launched a final-stage clinical trial of their...

San Diego's Neurocrine Biosciences Scores Second Big Deal in Two Daysmore

Neurocrine Biosciences (Nasdaq: NBIX) The deal was with Abbott Laboratories (Nasdaq: ABT) Neurocrine also stands to...

Discovery Labs, FelCor: Volume Moversmore

04 million. On Wednesday, shares of Neurocrine jumped 14.2% after the company signed a collaboration deal with Abbott...

Dad + Daughter -- Bankers = $3.7 Billion Dealmore

lined up at this carefully chosen neutral location. They met up with Miles White, chairman of $30 billion Abbott...

Abbott To Pay Neurocrine Up To $575 Million In Endometriosis Dealmore

DOW JONES NEWSWIRES Abbott Laboratories(ABT) has agreed to pay as much as $575 million as part of a deal to help...

Abbott's has new contact lens solutionmore

billion global market because it was linked to damaging eye infections, and then relying on an older version, Abbott...

Pfizer Drug Targets Gene Flaw to Shrink Lung Tumors (Update1)more

its drugs to a specific tumors traits. In the case of crizotinib, Pfizer has partnered with rival drugmaker Abbott...

Pfizer Lung Cancer Drug Hits Gene Targetmore

of patients based on the biology of a tumor, you can develop therapies most likely to help them." Abbott...

CoaguSense Receives FDA Clearance for the CoaguSense Blood Coagulation...more

com. CoaguSense and CoaguSense PT/INR Monitoring System are trademarks of CoaguSense, Inc. Abbott is a registered...

UPDATE: Abbott Labs Selling Debt After Buying Several Companiesmore

(adds size of the deal, launch level) NEW YORK (Dow Jones)--Abbott Laboratories (ABT), which recently has taken steps...

Abbott to pay $3.7 bln for unit of Piramal Healthcaremore

By Sumeet Chatterjee and Bharghavi Nagaraju MUMBAI (Reuters) - Abbott Laboratories Inc will pay $3.72 billion to...

Abbott acquisition to make it India's biggest drug-makermore

Abbott Laboratories will buy Piramal Healthcare���s branded generic-medicine unit in India for $3.72 billion (���2.

Abbott deal set to bolster emerging markets sharemore

Extract not available.

Abbott Labs to Buy Indian Drug Makermore

Abbott Laboratories agreed to buy Piramal Healthcare Ltd.'s generic drugs unit for about $3.72 billion, the latest in a...

Abbott Labs buying Indian drug makermore

Abbott Laboratories said yesterday that it would purchase the Indian drug maker Piramal Healthcare for $3.

Abbott to pay $3.7 bln for unit of India's Piramal - Reutersmore

8 pct; Abbott rises 1 pct (Adds analyst comment, moves into emerging markets) MUMBAI, May 21 (Reuters) - Abbott...

Abbott to buy Piramal business for $3.72 bnmore

ENS Economic BureauTags : Daiichi Sankyo, Abbott Laboratories, Indian pharma sector Posted: Sat May 22 2010, 02:36 hrs...

Abbott in $3.7 Billion Deal for Piramal Unit in Indiamore

Abbott Laboratories will pay $3.72 billion to acquire India���s Piramal Healthcare���s pharmaceutical solutions...

Abbott buys India drugs unit for $3.7bnmore

Extract not available.

Abbott to acquire Piramal business for $3.7 blnmore

LONDON (MarketWatch) -- Abbott Laboratories /quotes/comstock/13*!abt/quotes/nls/abt (ABT 46.48, -1.46, -3.

Abbott to Buy India Piramal's Health Unit for $3.7 Billionmore

MUMBAI (Reuters) - Abbott Laboratories Inc will pay $3.72 billion to acquire India's Piramal Healthcare's...

Top Sources: Abbott Laboratories

  • BusinessWeek
  • MarketWatch
  • Reuters
  • Chicago Tribune
  • thedeal.com
  • chicagobusiness.com
  • CNN Money
  • TheStreet.com
  • CNBC
  • innovationexcellence.com

Most Active Users in this Topic

see all contributors in Abbott Laboratories

Featured White Papers

Post a Job

Jobs in this Topic

Director, Laboratory Operations Abbott Laboratories | Irvine, CA
Posted: Jan 30
SENIOR REGULATORY AFFAIRS SPECIALIST Abbott Laboratories | Santa Clara, CA
Posted: Mar 26
WAREHOUSE SUPERVISOR Abbott Laboratories | Milpitas, CA
Posted: May 2
Project Manager, Commercial Abbott Laboratories | Santa Ana, CA
Posted: Apr 26
Sr Product Manager, US Endovascular Abbott Laboratories | Santa Clara, CA
Posted: May 13

Report comment contains invalid characters. ()
cancel
Search Cancel